MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,464,000 | -24.7% | 9,829,354 | -2.1% | 0.03% | -27.7% |
| Q2 2022 | $11,240,000 | -12.7% | 10,035,970 | -12.7% | 0.05% | -7.8% |
| Q1 2022 | $12,874,000 | -24.2% | 11,495,000 | +8.3% | 0.05% | -25.0% |
| Q4 2021 | $16,976,000 | -29.7% | 10,610,000 | +6.4% | 0.07% | -35.8% |
| Q3 2021 | $24,140,000 | -24.7% | 9,975,000 | -1.3% | 0.11% | -26.4% |
| Q2 2021 | $32,040,000 | +14.9% | 10,107,189 | +22.1% | 0.14% | +10.8% |
| Q1 2021 | $27,892,000 | +3643.9% | 8,276,500 | +2809.5% | 0.13% | +3150.0% |
| Q3 2020 | $745,000 | -35.1% | 284,469 | -24.1% | 0.00% | -42.9% |
| Q2 2020 | $1,148,000 | – | 375,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |